Among Swedish memory-clinic patients without dementia, more stressful life events were linked to a spinal-fluid sign of Alzheimer’s amyloid buildup, but only in people with moderate-to-high insomnia symptoms, according to a 2026 study.1 Research Highlights Stress and insomnia worked together: in 103 patients with spinal-fluid tests, lifetime stressful events and insomnia symptoms interacted in relation …
A 2026 ALZAN memory-clinic cohort found that cerebrospinal-fluid alpha-synuclein seed amplification assay detected 19 of 20 Lewy body dementia cases, with 95% sensitivity and 93.5% specificity against non-Lewy-body, non-Alzheimer’s controls.1 The same assay was positive in 32 of 203 Alzheimer’s disease patients, which makes the result a co-pathology warning as much as a diagnostic win. …
A 2026 immunopsychiatry cohort study found that soluble CD27 (sCD27), a marker of T-cell activation, was positive in cerebrospinal fluid in 23% of severe psychiatric patients selected for suspected immune involvement and in 88% of multiple sclerosis patients used as a positive-control group. In the psychiatric cohort, combined cerebrospinal fluid or blood sCD27 positivity was …